Use of gonococcal W serogrouping in the evaluation of a clinical trial of rosoxacin.
Rudén A K, Werner Y K, Ringertz O, +3 more·Sexually transmitted diseases
Serogrouping by co-agglutination was used for the characterization of isolates of Neisseria gonorrhoeae in a clinical trial of rosoxacin in Stockholm. Twenty-four isolates (56%) belonged to serogroup WI, 17 (40%) to WII, and two (5%) to WIII. The proportion of WI isolates in Stockholm was reported in earlier studies to…